Literature DB >> 20943386

Apoptotic action of ursolic acid isolated from Corni fructus in RC-58T/h/SA#4 primary human prostate cancer cells.

Seong-Hyuk Kwon1, Hye-Young Park, Jae-Yong Kim, Il-Yun Jeong, Mi-Kyung Lee, Kwon-Il Seo.   

Abstract

Ursolic acid (3β-hydroxy-urs-12-en-28-oic acid) is a major biological active component of Corni fructus that is known to induce apoptosis. However, the apoptotic mechanism of ursolic acid using primary malignant tumor (RC-58T/h/SA#4)-derived human prostate cells is not known. In the present study, ursolic acid significantly inhibited the growth of RC-58T/h/SA#4 cells in dose- and time-dependent manners. Ursolic acid induced cell death as evidenced by an increased proportion of cells in sub-G1 phase, the formation of apoptotic bodies, nuclear condensation, and DNA fragmentation. After ursolic acid treatment at concentrations above 40 μM, the activities of caspase-3, -8, and -9 were significantly increased compared that of control. Ursolic acid modulated the upregulation of Bax (pro-apoptotic) as well as the downregulation of Bcl-2 (anti-apoptotic). Ursolic acid also stimulated Bid cleavage, which indicates that the apoptotic action of caspase-8-mediated Bid cleavage leads to the activation of caspase-9. Thus, the apoptotic effect of ursolic acid was involved in extrinsic and intrinsic signaling pathways. In addition, ursolic acid increased the expression of the caspase-independent mitochondrial apoptosis factor (AIF) in RC-58T/h/SA#4 cells. The present results suggest that ursolic acid from Corni fructus activated apoptosis in RC-58T/h/SA#4 cells via both caspase-dependent and -independent pathways.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20943386     DOI: 10.1016/j.bmcl.2010.09.073

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

Review 1.  Research progress of ursolic acid's anti-tumor actions.

Authors:  Li-li Zang; Bao-ning Wu; Yuan Lin; Jun Wang; Lei Fu; Ze-yao Tang
Journal:  Chin J Integr Med       Date:  2013-12-29       Impact factor: 1.978

2.  Anti-cancer natural products isolated from chinese medicinal herbs.

Authors:  Wen Tan; Jinjian Lu; Mingqing Huang; Yingbo Li; Meiwan Chen; Guosheng Wu; Jian Gong; Zhangfeng Zhong; Zengtao Xu; Yuanye Dang; Jiajie Guo; Xiuping Chen; Yitao Wang
Journal:  Chin Med       Date:  2011-07-22       Impact factor: 5.455

Review 3.  Chinese medicines induce cell death: the molecular and cellular mechanisms for cancer therapy.

Authors:  Xuanbin Wang; Yibin Feng; Ning Wang; Fan Cheung; Hor Yue Tan; Sen Zhong; Charlie Li; Seiichi Kobayashi
Journal:  Biomed Res Int       Date:  2014-10-14       Impact factor: 3.411

Review 4.  Ursolic Acid-Based Derivatives as Potential Anti-Cancer Agents: An Update.

Authors:  Vuyolwethu Khwaza; Opeoluwa O Oyedeji; Blessing A Aderibigbe
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 5.923

Review 5.  The Most Competent Plant-Derived Natural Products for Targeting Apoptosis in Cancer Therapy.

Authors:  Sadegh Rajabi; Marc Maresca; Alexei Valerievich Yumashev; Rasool Choopani; Homa Hajimehdipoor
Journal:  Biomolecules       Date:  2021-04-03

6.  Iridoids, Flavonoids, and Antioxidant Capacity of Cornus mas, C. officinalis, and C. mas × C. officinalis Fruits.

Authors:  Svitlana Klymenko; Alicja Zofia Kucharska; Anna Sokół-Łętowska; Narcyz Piórecki; Dominika Przybylska; Olga Grygorieva
Journal:  Biomolecules       Date:  2021-05-21

7.  Physicochemical and Sensory Properties of Yogurt Supplemented with Corni fructus during Storage.

Authors:  Hyo Ju Noh; Hye Min Seo; Jun Ho Lee; Yoon Hyuk Chang
Journal:  Prev Nutr Food Sci       Date:  2013-03

8.  Effects of Chinese Medicine as Adjunct Medication for Adjuvant Chemotherapy Treatments of Non-Small Cell Lung Cancer Patients.

Authors:  Lijing Jiao; Changsheng Dong; Jiaxiang Liu; Zhiwei Chen; Lei Zhang; Jianfang Xu; Xiaoyong Shen; Jiaming Che; Yi Yang; Hai Huang; Hegen Li; Jianli Sun; Yi Jiang; Zhujun Mao; Peiqi Chen; Yabin Gong; Xiaolin Jin; Ling Xu
Journal:  Sci Rep       Date:  2017-04-24       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.